D.E. Shaw & Co’s Aehr Test Systems AEHR Stock Holding History

D.E. Shaw & Co’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.7M	Buy	341,638 +51,347	+18%	+$1.64M	0.01%	1440
2025 Q4	$5.86M	Buy	290,291 +55,917	+24%	+$1.35M	﹤0.01%	2182
2025 Q3	$7.06M	Buy	+234,374	New	+$5.08M	﹤0.01%	1935
2024 Q2	–	Sell	-52,443	Closed	-$611K	–	4444
2024 Q1	$650K	Sell	52,443 -275,429	-84%	-$4.59M	﹤0.01%	3353
2023 Q4	$8.7M	Buy	327,872 +54,879	+20%	+$1.6M	0.01%	1473
2023 Q3	$12.5M	Sell	272,993 -323,301	-54%	-$15M	0.01%	1128
2023 Q2	$24.6M	Buy	596,294 +315,645	+112%	+$10.4M	0.03%	768
2023 Q1	$8.71M	Buy	+280,649	New	+$9.04M	0.01%	1480
2022 Q2	–	Sell	-88,844	Closed	-$903K	–	5298
2022 Q1	$903K	Buy	+88,844	New	+$1.14M	﹤0.01%	3999

Other funds holding AEHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's AEHR Position: Q1 2026 in Review

D.E. Shaw & Co increased its Aehr Test Systems (AEHR) stake by 18% in Q1 2026, buying an estimated $1.64M and bringing the position to 341,638 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #1440.

D.E. Shaw & Co first reported a position in AEHR in Q1 2022 and has held it in 9 quarters since. The position peaked at $24.6M in Q2 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

D.E. Shaw & Co held 341,638 shares of Aehr Test Systems worth $12.7M as of Q1 2026.
D.E. Shaw & Co bought 51,347 Aehr Test Systems shares in Q1 2026, an estimated $1.64M.
Aehr Test Systems made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1440 holding.
D.E. Shaw & Co first reported a position in Aehr Test Systems in Q1 2022 and has held it in 9 quarters since.
D.E. Shaw & Co's Aehr Test Systems position peaked at $24.6M in Q2 2023.
191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.